Pro-inflammatory interleukins such as IL-1, IL-6, and IL-8 facilitate osteoclastogenesis, tumor proliferation, and angiogenesis, thereby contributing to the complex interactions within the bone microenvironment that drive metastatic disease. The gene discussed is IL1A; the disease is metastatic neoplasm.